Related Experiment Video
Updated: Sep 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
[Interactive pathway of ARF-mdm2-p53]
1Department of Pathology, Changhai Hospital, The Second Military Medical University, Shanghai, 200433, P.R. China.
Abstract:
The inhibitor of cyclin-dependent kinase 4-p16INK4 alpha and its alterative reading frame (ARF)-INK4/ARF gene locates at CDKN2A locus of human chromosome 9p21. This locus encodes two overlapped genes: ARF gene and p16INK4 alpha. The amino acid sequences of two genes are completely different because they are encoded by alternative reading frames. ARF participates in the regulation of mdm2-p53 pathway by mdm2. Recent studies showed that ARF gene may play a role in tumorigenesis; the ARF gene promoter hypermethylation may be the principal mechanism in the inactivation of this gene. Here is a review of ARF-mdm2-p53 interacting pathway.
Insights
The ARF gene, located at human chromosome 9p21, plays a role in cancer. Promoter hypermethylation may inactivate the ARF gene, impacting the mdm2-p53 pathway.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- The CDKN2A locus on human chromosome 9p21 encodes two distinct genes, p16INK4 alpha and ARF, via alternative reading frames.
- These genes, despite their shared locus, produce proteins with entirely different amino acid sequences.
- The ARF gene is implicated in regulating the mdm2-p53 pathway.
Purpose of the Study:
- To review the intricate interactions within the ARF-mdm2-p53 pathway.
- To explore the role of the ARF gene in tumorigenesis.
- To highlight promoter hypermethylation as a key mechanism for ARF gene inactivation.
Main Methods:
- Literature review of studies on the ARF-mdm2-p53 pathway.
- Analysis of genetic and epigenetic alterations affecting the CDKN2A locus.
- Examination of the functional consequences of ARF inactivation in cancer.
Main Results:
- The ARF gene's interaction with mdm2 is crucial for p53 regulation.
- Evidence suggests the ARF gene's involvement in the development of various cancers.
- ARF gene promoter hypermethylation is identified as a primary mechanism leading to its functional loss.
Conclusions:
- The ARF-mdm2-p53 pathway is a significant target in cancer research.
- Understanding ARF gene inactivation mechanisms, particularly hypermethylation, is vital for therapeutic strategies.
- Further research into this pathway could yield novel insights into cancer prevention and treatment.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules

